Vapotherm registers $58m IPO

Vapotherm last week registered for an initial public offering worth nearly $58 million for the respiratory device it’s developing.

Exeter, N.H.-based Vapotherm developed the Precision Flow line of devices to provide high-velocity heated, humidified and oxygenated air to treat patients with conditions such as pneumonia, chronic obstructive pulmonary disease, asthma and heart failure. Some 1,200 of the devices have been sold in the U.S., mostly into hospital ICUs, the company said.